| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.00024 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 9.2e-05 | 1 |